Ellen A. Ronnen

800 total citations
10 papers, 580 citations indexed

About

Ellen A. Ronnen is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Economics and Econometrics. According to data from OpenAlex, Ellen A. Ronnen has authored 10 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 4 papers in Economics and Econometrics. Recurrent topics in Ellen A. Ronnen's work include Renal cell carcinoma treatment (7 papers), Cancer Genomics and Diagnostics (4 papers) and Renal and related cancers (4 papers). Ellen A. Ronnen is often cited by papers focused on Renal cell carcinoma treatment (7 papers), Cancer Genomics and Diagnostics (4 papers) and Renal and related cancers (4 papers). Ellen A. Ronnen collaborates with scholars based in United States. Ellen A. Ronnen's co-authors include Robert J. Motzer, Nicole Ishill, G. Varuni Kondagunta, Jennifer Bacik, Michelle S. Ginsberg, Michael Baum, Darren R. Feldman, Hani Hassoun, Carlos D. Flombaum and Sujata Patil and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Urology.

In The Last Decade

Ellen A. Ronnen

10 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen A. Ronnen United States 8 391 321 195 133 70 10 580
Sasja F. Mulder Netherlands 12 265 0.7× 340 1.1× 130 0.7× 253 1.9× 43 0.6× 38 669
S. Srinivas United States 13 410 1.0× 527 1.6× 264 1.4× 282 2.1× 102 1.5× 38 816
Silvia Bombelli Italy 12 366 0.9× 287 0.9× 187 1.0× 105 0.8× 61 0.9× 22 603
Peter Choyke United States 12 272 0.7× 133 0.4× 277 1.4× 212 1.6× 207 3.0× 20 649
Kyosuke Matsuzaki Japan 10 313 0.8× 184 0.6× 236 1.2× 90 0.7× 109 1.6× 39 538
Amit Mehta United States 12 197 0.5× 300 0.9× 115 0.6× 183 1.4× 126 1.8× 18 667
L. Wood United States 12 254 0.6× 333 1.0× 126 0.6× 185 1.4× 25 0.4× 23 481
Ellen Blanc France 12 278 0.7× 357 1.1× 180 0.9× 139 1.0× 58 0.8× 34 524
Hideaki Miyake Japan 10 372 1.0× 201 0.6× 236 1.2× 316 2.4× 56 0.8× 13 666
Mark R. Olsen United States 12 257 0.7× 591 1.8× 174 0.9× 416 3.1× 48 0.7× 20 774

Countries citing papers authored by Ellen A. Ronnen

Since Specialization
Citations

This map shows the geographic impact of Ellen A. Ronnen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen A. Ronnen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen A. Ronnen more than expected).

Fields of papers citing papers by Ellen A. Ronnen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen A. Ronnen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen A. Ronnen. The network helps show where Ellen A. Ronnen may publish in the future.

Co-authorship network of co-authors of Ellen A. Ronnen

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen A. Ronnen. A scholar is included among the top collaborators of Ellen A. Ronnen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen A. Ronnen. Ellen A. Ronnen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Pergolotti, Mackenzi, et al.. (2024). Geriatric assessment-identified impairments and frailty in adults with cancer younger than 65: An opportunity to optimize oncology care. Journal of Geriatric Oncology. 15(4). 101751–101751. 3 indexed citations
2.
Dillmon, Melissa S., Erin B. Kennedy, H. N. COHEN, et al.. (2019). Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards. Journal of Clinical Oncology. 38(6). 633–644. 21 indexed citations
3.
Feldman, Darren R., Michael Baum, Michelle S. Ginsberg, et al.. (2009). Phase I Trial of Bevacizumab Plus Escalated Doses of Sunitinib in Patients With Metastatic Renal Cell Carcinoma. Journal of Clinical Oncology. 27(9). 1432–1439. 239 indexed citations
4.
Feldman, Darren R., Michelle S. Ginsberg, Michael Baum, et al.. (2008). Phase I trial of bevacizumab plus sunitinib in patients with metastatic renal cell carcinoma. Journal of Clinical Oncology. 26(15_suppl). 5100–5100. 33 indexed citations
5.
Feldman, Darren R., G. Varuni Kondagunta, Ellen A. Ronnen, et al.. (2007). Phase I trial of bevacizumab plus sunitinib in patients (pts) with metastatic renal cell carcinoma (mRCC). Journal of Clinical Oncology. 25(18_suppl). 5099–5099. 25 indexed citations
6.
Ronnen, Ellen A., G. Varuni Kondagunta, Nicole Ishill, et al.. (2006). A phase II trial of 17-(Allylamino)-17-demethoxygeldanamycin in patients with papillary and clear cell renal cell carcinoma. Investigational New Drugs. 24(6). 543–546. 125 indexed citations
7.
Ronnen, Ellen A., G. Varuni Kondagunta, Nicole Ishill, et al.. (2006). Treatment outcome for metastatic papillary renal cell carcinoma patients. Cancer. 107(11). 2617–2621. 68 indexed citations
8.
Ronnen, Ellen A., G. Varuni Kondagunta, Michelle S. Ginsberg, Paul Russo, & Robert J. Motzer. (2006). Long-term response with sunitinib for metastatic renal cell carcinoma. Urology. 68(3). 672.e19–672.e20. 7 indexed citations
9.
Ronnen, Ellen A., G. Varuni Kondagunta, Christopher Lau, et al.. (2006). A phase I study of sunitinib malate (SU11248) in combination with gefitinib in patients with metastatic renal cell carcinoma (mRCC). Journal of Clinical Oncology. 24(18_suppl). 4537–4537. 10 indexed citations
10.
Ronnen, Ellen A., G. Varuni Kondagunta, Jennifer Bacik, et al.. (2005). Incidence of Late-Relapse Germ Cell Tumor and Outcome to Salvage Chemotherapy. Journal of Clinical Oncology. 23(28). 6999–7004. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sasja F. Mulder Breakdown of academic impact, for papers by S. Srinivas Breakdown of academic impact, for papers by Silvia Bombelli Breakdown of academic impact, for papers by Peter Choyke Breakdown of academic impact, for papers by Kyosuke Matsuzaki Breakdown of academic impact, for papers by Amit Mehta Breakdown of academic impact, for papers by L. Wood Breakdown of academic impact, for papers by Ellen Blanc Breakdown of academic impact, for papers by Hideaki Miyake Breakdown of academic impact, for papers by Mark R. Olsen
Rankless by CCL
2026